Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Ganz

Showing results (81-90 of 200) with videos related to

Pageof 20
Sort By:
Diabetes Care|June 13, 2020
Mechanisms of Sodium-Glucose Cotransporter 2 Inhibition: Insights From Large-Scale ProteomicsEle Ferrannini, Ashwin C Murthy, Yong-Ho Lee, et al.
Journal of the American College of Cardiology|February 2, 2010
Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score?Andre B Araujo, Susan A Hall, Peter Ganz, et al.
Circulation|September 17, 2003
High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL studyScott Kinlay, Gregory G Schwartz, Anders G Olsson, et al.
The Journal of Sexual Medicine|February 13, 2009
Is hyperlipidemia or its treatment associated with erectile dysfunction?: Results from the Boston Area Community Health (BACH) SurveySusan A Hall, Varant Kupelian, Raymond C Rosen, et al.
Circulation|October 5, 2017
Improving Assessment of Drug Safety Through Proteomics: Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of TorcetrapibStephen A Williams, Ashwin C Murthy, Robert K DeLisle, et al.
Journal of the American College of Cardiology|December 1, 2018
IL-1β Inhibition Reduces Atherosclerotic Inflammation in HIV InfectionPriscilla Y Hsue, Danny Li, Yifei Ma, et al.
European Heart Journal|March 15, 2005
High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trialAnders G Olsson, Gregory G Schwartz, Michael Szarek, et al.
Atherosclerosis|May 29, 2013
Elevated levels of asymmetric dimethylarginine are associated with lower CD4+ count and higher viral load in HIV-infected individualsRushi V Parikh, Rebecca Scherzer, Carl Grunfeld, et al.
Journal of the American Heart Association|May 1, 2016
HIV and Hepatitis C-Coinfected Patients Have Lower Low-Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent "PCSK9-Lipid Paradox"Payal Kohli, Peter Ganz, Yifei Ma, et al.
AIDS (London, England)|March 3, 2012
The association of CD4+ T-cell counts and cardiovascular risk in treated HIV diseaseJennifer E Ho, Rebecca Scherzer, Frederick M Hecht, et al.
Pageof 20

Showing results (81-90 of 200) with videos related to

Sort By:
Pageof 20
Diabetes Care|June 13, 2020
Mechanisms of Sodium-Glucose Cotransporter 2 Inhibition: Insights From Large-Scale ProteomicsEle Ferrannini, Ashwin C Murthy, Yong-Ho Lee, et al.
Journal of the American College of Cardiology|February 2, 2010
Does erectile dysfunction contribute to cardiovascular disease risk prediction beyond the Framingham risk score?Andre B Araujo, Susan A Hall, Peter Ganz, et al.
Circulation|September 17, 2003
High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL studyScott Kinlay, Gregory G Schwartz, Anders G Olsson, et al.
The Journal of Sexual Medicine|February 13, 2009
Is hyperlipidemia or its treatment associated with erectile dysfunction?: Results from the Boston Area Community Health (BACH) SurveySusan A Hall, Varant Kupelian, Raymond C Rosen, et al.
Circulation|October 5, 2017
Improving Assessment of Drug Safety Through Proteomics: Early Detection and Mechanistic Characterization of the Unforeseen Harmful Effects of TorcetrapibStephen A Williams, Ashwin C Murthy, Robert K DeLisle, et al.
Journal of the American College of Cardiology|December 1, 2018
IL-1β Inhibition Reduces Atherosclerotic Inflammation in HIV InfectionPriscilla Y Hsue, Danny Li, Yifei Ma, et al.
European Heart Journal|March 15, 2005
High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trialAnders G Olsson, Gregory G Schwartz, Michael Szarek, et al.
Atherosclerosis|May 29, 2013
Elevated levels of asymmetric dimethylarginine are associated with lower CD4+ count and higher viral load in HIV-infected individualsRushi V Parikh, Rebecca Scherzer, Carl Grunfeld, et al.
Journal of the American Heart Association|May 1, 2016
HIV and Hepatitis C-Coinfected Patients Have Lower Low-Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent "PCSK9-Lipid Paradox"Payal Kohli, Peter Ganz, Yifei Ma, et al.
AIDS (London, England)|March 3, 2012
The association of CD4+ T-cell counts and cardiovascular risk in treated HIV diseaseJennifer E Ho, Rebecca Scherzer, Frederick M Hecht, et al.
Pageof 20